$UNUM

Company: Unum Therapeutics, Inc. Symbol: UNUM Description: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. Trade Date: 3/29 Shares: 5.77 million Price Range: $12.00-$14.00 Underwriter(s): Morgan Stanley, Cowen Co-Manager: SunTrust Robinson, Wedbush PacGrow Terms[…]